Recombinant Human BAFF/BLyS/TNFSF13B Protein
R&D Systems, part of Bio-Techne | Catalog # 2149-BF
Key Product Details
Product Specifications
Source
MHHHHHHHHHH | GGGSGGGSGGGS | IEGR | Human BAFF (Ala134-Leu285) Accession # Q9Y275.1 |
N-terminus | C-terminus |
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
The ED50 for this effect is 0.4-2 ng/mL in the presence of goat anti‑mouse IgM µ chain.
Reviewed Applications
Read 4 reviews rated 5 using 2149-BF in the following applications:
Formulation, Preparation and Storage
Carrier Free
What does CF mean?CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
What formulation is right for me?In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
Carrier: 2149-BF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS, EDTA and DTT with BSA as a carrier protein. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Carrier Free: 2149-BF/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS, EDTA and DTT. |
Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: BAFF/BLyS/TNFSF13B
References
- Lied, G.A. and A. Berstad (2011) Scand. J. Immunol. 73:1.
- Mackay, F. et al. (2010) Immunol. Rev. 237:205.
- Moore, P.A. et al. (1999) Science 285:260.
- Schneider, P. et al. (1999) J. Exp. Med. 189:1747.
- Roschke, V. et al. (2002) J. Immunol. 169:4314.
- Scapini, P. et al. (2003) J. Exp. Med. 197:297.
- Gavin, A.L. et al. (2003) J. Biol. Chem. 278:38220.
- Alexaki, V.-I. et al. (2009) J. Immunol. 183:5948.
- Yu, G. et al. (2000) Nat. Immunol. 1:252.
- Thompson, J.S. et al. (2001) Science 293:2108.
- Schiemann, B. et al. (2001) Science 293:2111.
- Litinskiy, M.B. et al. (2002) Nat. Immunol. 3:822.
- Batten, M. et al. (2000) J. Exp. Med. 192:1453.
- Huard, B. et al. (2001) J. Immunol. 167:6225.
- Sutherland, A.P.R. et al. (2005) J. Immunol. 174:5537.
- Walters, S. et al. (2009) J. Immunol. 182:793.
- Chang, S.K. et al. (2006) Blood 108:2687.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional BAFF/BLyS/TNFSF13B Products
Product Documents for Recombinant Human BAFF/BLyS/TNFSF13B Protein
Product Specific Notices for Recombinant Human BAFF/BLyS/TNFSF13B Protein
For research use only